ID

37941

Descripción

Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women; ODM derived from: https://clinicaltrials.gov/show/NCT01300351

Link

https://clinicaltrials.gov/show/NCT01300351

Palabras clave

Versiones (1)
  1. 1/9/19 1/9/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

1 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01300351

Inglés

Eligibility Breast Cancer NCT01300351

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
postmenopausal women defined as a woman who has stopped having menstrual periods
Descripción

Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
breast cancer has continued to grow after having received treatment with an anti-estrogen hormonal treatment such as tamoxifen or an aromatase inhibitor
Descripción

Breast Carcinoma | Disease Progression | Status post Antioestrogen therapy | Tamoxifen | Aromatase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0242656
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0854638
UMLS CUI [4]
C0039286
UMLS CUI [5]
C0593802
requiring hormonal treatment
Descripción

Requirement Hormone Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514873
UMLS CUI [1,2]
C0279025
oestrogen-receptor positive tumour
Descripción

Estrogen receptor positive tumor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1562312
written informed consent to participate in the trial
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with an investigational or non-approved drug within one month
Descripción

Investigational New Drugs | Drugs, Non-Prescription

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C0013231
an existing serious disease, illness, or condition that will prevent participation or compliance with study procedures
Descripción

Illness Serious Study Subject Participation Status Excluded | Condition Serious Study Subject Participation Status Excluded | Illness Serious Preventing Protocol Compliance | Condition Serious Preventing Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C2348568
UMLS CUI [1,4]
C0332196
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C2348568
UMLS CUI [2,4]
C0332196
UMLS CUI [3,1]
C0221423
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C1292733
UMLS CUI [3,4]
C0525058
UMLS CUI [4,1]
C0348080
UMLS CUI [4,2]
C0205404
UMLS CUI [4,3]
C1292733
UMLS CUI [4,4]
C0525058
a history of allergies to any active or inactive ingredients of fulvestrant (i.e. castor oil)
Descripción

Hypersensitivity Fulvestrant Ingredient | Castor oil allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0935916
UMLS CUI [1,3]
C1550600
UMLS CUI [2]
C0571232
treatment with more than one regimen of chemotherapy for advanced breast cancer
Descripción

Chemotherapy Regimen Quantity Advanced breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C3495917
treatment with more than one regimen of hormonal treatment for advanced breast cancer
Descripción

Hormone Therapy Quantity Advanced breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C3495917
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT01300351

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Postmenopausal state
Item
postmenopausal women defined as a woman who has stopped having menstrual periods
boolean
C0232970 (UMLS CUI [1])
Breast Carcinoma | Disease Progression | Status post Antioestrogen therapy | Tamoxifen | Aromatase Inhibitors
Item
breast cancer has continued to grow after having received treatment with an anti-estrogen hormonal treatment such as tamoxifen or an aromatase inhibitor
boolean
C0678222 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C0854638 (UMLS CUI [3,2])
C0039286 (UMLS CUI [4])
C0593802 (UMLS CUI [5])
Requirement Hormone Therapy
Item
requiring hormonal treatment
boolean
C1514873 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
Estrogen receptor positive tumor
Item
oestrogen-receptor positive tumour
boolean
C1562312 (UMLS CUI [1])
Informed Consent
Item
written informed consent to participate in the trial
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs | Drugs, Non-Prescription
Item
treatment with an investigational or non-approved drug within one month
boolean
C0013230 (UMLS CUI [1])
C0013231 (UMLS CUI [2])
Illness Serious Study Subject Participation Status Excluded | Condition Serious Study Subject Participation Status Excluded | Illness Serious Preventing Protocol Compliance | Condition Serious Preventing Protocol Compliance
Item
an existing serious disease, illness, or condition that will prevent participation or compliance with study procedures
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0332196 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C0332196 (UMLS CUI [2,4])
C0221423 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C1292733 (UMLS CUI [3,3])
C0525058 (UMLS CUI [3,4])
C0348080 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
C1292733 (UMLS CUI [4,3])
C0525058 (UMLS CUI [4,4])
Hypersensitivity Fulvestrant Ingredient | Castor oil allergy
Item
a history of allergies to any active or inactive ingredients of fulvestrant (i.e. castor oil)
boolean
C0020517 (UMLS CUI [1,1])
C0935916 (UMLS CUI [1,2])
C1550600 (UMLS CUI [1,3])
C0571232 (UMLS CUI [2])
Chemotherapy Regimen Quantity Advanced breast cancer
Item
treatment with more than one regimen of chemotherapy for advanced breast cancer
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3495917 (UMLS CUI [1,3])
Hormone Therapy Quantity Advanced breast cancer
Item
treatment with more than one regimen of hormonal treatment for advanced breast cancer
boolean
C0279025 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3495917 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial